HPV vaccination success

A routine human papillomavirus (HPV) vaccination of girls aged 12 to 13 in Scotland has led to a significant reduction in cervical disease in later life, according to a study published by the British Medical Journal.

Researchers analysed vaccination and screening records for 138,692 women born between 1988 and 1996 who had a screening test result recorded at age 20.

After taking account of other important factors, vaccinated women born in 1995 and 1996 showed a 79-89 per cent reduction in levels of abnormal cells and cervical lesions compared with unvaccinated women born in 1988. 

In addition, a younger age at vaccination was associated with increasing vaccine effectiveness. Unvaccinated women also showed a reduction in cervical disease, which the researchers put down to herd protection.

The researchers concluded: “The findings emphasise the credibility of using high-risk HPV infection as an early marker of the effectiveness and success of the vaccine and underpin the recent call for global action on cervical cancer.”

Recommended

Helping to stop strokes

All about activity




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Training Matters's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.